Role of HSCT in children and adolescents with refractory or relapsed NHL

被引：0

作者：

Burkhardt, Birgit ^{[1
]}

Pillon, Marta ^{[2
]}

Taj, Mary ^{[3
]}

Garnier, Nathalie ^{[4
]}

Minard, Veronique ^{[5
]}

Hazar, Volkan ^{[6
,7
,8
]}

Mellgren, Karin ^{[9
]}

Osumi, Tomoo ^{[10
]}

Fedorova, Alina ^{[11
]}

Myakova, Natalia ^{[12
]}

Verdu-Amoros, Jaime ^{[13
]}

Andres, Mara ^{[14
]}

Kabickova, Edita ^{[15
,16
]}

Attarbaschi, Andishe ^{[17
]}

Chiang, Alan ^{[18
]}

Bubanska, Eva ^{[19
,20
]}

Donska, Svetlana ^{[21
]}

Hjalgrim, Lisa L. ^{[22
]}

Wachowiak, Jacek ^{[23
]}

Pieczonka, Anna ^{[23
]}

Uyttebroeck, Anne ^{[24
]}

Loeffen, Jan ^{[25
]}

Buechner, Jochen ^{[26
]}

Niggli, Felix ^{[27
]}

Palma, Julia ^{[28
]}

Burke, Amos ^{[29
]}

Beishuizen, Auke ^{[25
]}

Koeppen, Kristin ^{[1
]}

Herbrueggen, Heidi ^{[1
]}

Woessmann, Wilhelm ^{[30
]}

Zimmermann, Martin ^{[31
]}

Balduzzi, Adriana ^{[32
]}

机构：

[1] Univ Hosp Muenster, Dept Pediat Hematol Oncol & BMT, Munster, Germany

[2] Univ Hosp Padua, Dept Child & Woman Hlth, Div Hematol Oncol, Padua, Italy

[3] Royal Marsden Hosp, Dept Paediat Oncol, Sutton, Surrey, England

[4] Hosp Civils Lyon, Inst Pediat Hematol & Oncol, Lyon, France

[5] Gustave Roussy Canc Campus, Dept Pediat Oncol, Villejuif, France

[6] Med Pk Goztepe Hosp, Dept Pediat Hematol, Istanbul, Turkey

[7] Med Pk Goztepe Hosp, Dept Oncol, Istanbul, Turkey

[8] Med Pk Goztepe Hosp, BMT Unit, Istanbul, Turkey

[9] Queen Silvia Childrens Hosp, Dept Pediat Oncol & Hematol, Sahlgrenska Univ Hosp, Gothenburg, Sweden

[10] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan

[11] Belarusian Res Ctr Pediat Oncol Hematol & Immunol, Dept Clin Res, Minsk, BELARUS

[12] Fed Ctr Pediat Hematol Oncol & Immunol, Pediat Hematol & Oncol, Moscow, Russia

[13] Univ Hosp Valencia, Dept Pediat Hematol & Oncol, Valencia, Spain

[14] Univ Hosp Le Fe, Dept Pediat Oncol, Valencia, Spain

[15] Charles Univ Prague, Prague, Czech Republic

[16] Univ Hosp Motol, Dept Paediat Haematol & Oncol, Prague, Czech Republic

[17] Med Univ Vienna, St Anna Childrens Hosp, Dept Pediat Hematol & Oncol, Vienna, Austria

[18] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China

[19] Slovak Hlth Univ, Banska Bystrica, Slovakia

[20] Childrens Fac Hosp, Clin Pediat Oncol & Hematol, Banska Bystrica, Slovakia

[21] Natl Ukrainian Childrens Hosp Ochmatdyt, Ctr Pediat Oncohematol & BMT, Kiev, Ukraine

[22] Dept Paediat & Adolescent Med, Copenhagen, Denmark

[23] Poznan Univ Med Sci, Dept Pediat Oncol Hematol & Transplantol, Poznan, Poland

[24] Univ Hosp Gasthuisberg, Dept Paediat Haematol & Oncol, Leuven, Belgium

[25] Sophia Childrens Univ Hosp, Erasmus Med Ctr Rotterdam, Dept Pediat Oncol & Hematol, Rotterdam, Netherlands

[26] Oslo Univ Hosp, Dept Pediat Hematol & Oncol, Oslo, Norway

[27] Univ Childrens Hosp Zurich, Dept Pediat Oncol, Zurich, Switzerland

[28] Univ Chile, Fac Med, Hosp Luis Calvo Mackenna, Dept Pediat,Bone Marrow Transplantat Unit, Santiago, Chile

[29] Addenbrookes Hosp, Cambridge Univ Hosp NHS Fdn Trust, Dept Paediat Haematol & Oncol & Palliat Care, Cambridge, England

[30] Justus Liebig Univ, Dept Pediat Hematol & Oncol, Giessen, Germany

[31] Hannover Med Sch, Dept Pediat Hematol & Oncol, Hannover, Germany

[32] Univ Milano Bicocca, San Gerardo Hosp, Clin Pediat Univ Milano Bicocca, Monza, Italy

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 182卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：24 / 24

页数：1

共 50 条

[41] The role of ifosfamide in the treatment of relapsed and refractory lymphoma
Reiser, M
Bredenfeld, H
Engert, A
Diehl, V
EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 66 : 37 - 40
[42] The Role of Chemotherapy for Metastatic, Relapsed and Refractory Osteosarcoma
Xin Xiao
Wei Wang
Zhen Wang
Pediatric Drugs, 2014, 16 : 503 - 512
[43] The Role of Chemotherapy for Metastatic, Relapsed and Refractory Osteosarcoma
Xiao, Xin
Wang, Wei
Wang, Zhen
PEDIATRIC DRUGS, 2014, 16 (06) : 503 - 512
[44] Phase II study of oxaliplatin in patients with relapsed and refractory non-Hodgkin lymhoma (NHL)
Younes, A
McLaughlin, P
Pro, B
Hagemeister, F
Bleyer, A
BLOOD, 2003, 102 (11) : 639A - 640A
[45] IIVP salvage regimen induces high response rates in patients with relapsed FED or NHL prior to autologous HSCT.
Abali, H
Koc, Y
Oyan, B
Tekin, F
Tekuzman, G
Kansu, E
BLOOD, 2002, 100 (11) : 294B - 294B
[46] Gemcitabine as single agent in the treatment of relapsed or refractory aggressive non-Hodgkin lymphoma (NHL)
Welt, A
Fossa, A
Blatter, J
Buksmaui, S
Seeber, S
Nowrousian, MR
ANNALS OF ONCOLOGY, 1998, 9 : 168 - 168
[47] Combination of Lenalidomide and R-DHAP for Treatment of Relapsed and Refractory Aggressive B-NHL
Glass, Bertram
Goerlitz, Anke
Pfeiffer, Sebastian
Nickelsen, Maike
Huettmann, Andreas
Hasenkamp, Justin
Truemper, Lorenz H.
Dreyling, Martin
Kiehl, Michael G.
Salwender, Hans
Schmitz, Norbert
BLOOD, 2014, 124 (21)
[48] 3-YEAR RESULTS OF MIM SALVAGE TREATMENT FOR REFRACTORY/RELAPSED INTERMEDIATE GRADE NHL
ABATE, G
TAFUTO, S
MARCACCI, G
CORAZZELLI, G
FIMIANI, P
MONDA, VM
GAILLI, E
DANDREA, P
IACCARINO, G
EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 54 (01) : 53 - 54
[49] BEAM-alemtuzumab followed by allogeneic SCT for the treatment of relapsed or refractory T-NHL
Repp, R.
Guenther, A.
Schade, H.
Humpe, A.
Gahn, B.
Nickelsen, M.
Claviez, A.
Schrauder, A.
Gramatzki, M.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[50] PRESENCE OF SOLID TUMORS DOES NOT PREVENT AUTOLOGOUS STEM CELL TRANSPLANTATION IN REFRACTORY/RELAPSED NHL
Arslan, Ismail
Bilgin, Aynur Ugur
Ilhan, Osman
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 591 - 592

← 1 2 3 4 5 →